Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Entest BioMedical Inc. (ENTB)

Add ENTB Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator vegasdrummer, 1-eye-jack, stockchaser64, d5wr59mfi8, PetePham
Search This Board:
Last Post: 11/26/2014 4:56:48 PM - Followers: 489 - Board type: Free - Posts Today: 0

Entest BioMedical Inc. (ENTB)


Share Structure:

as of = 10/24/2014

O/S = 2,405,570,000 

A/S = 6,000,000,000

ENTB Transfer Agent 

Securities Transfer Corporation 
2591 Dallas Parkway Suite 102 
Frisco, Texas 75034 

Fax: 469-633-0088 
Phone: 469-633-0101






Company Information:                                                      
4700 Spring Street, Suite 304
La Mesa, Calif. 91942
Telephone: 619-644-3344
Fax: 619-330-2328

Web site:


CIK 0001449447

ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines


In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)

Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).

Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.

Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.

Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.



David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance






  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ENTB News: Annual Report (10-k) 11/26/2014 11:18:00 AM
ENTB News: Current Report Filing (8-k) 07/14/2014 04:36:32 PM
ENTB News: Quarterly Report (10-q) 07/09/2014 03:42:59 PM
News News Alert: Annual Report (10-k) 11/26/2014 11:18:00 AM
#36034  Sticky Note Entest BioMedical's ImenVax(TM) Cancer Vaccine Appears to Slow PetePham 10/26/14 10:28:49 PM
#34823  Sticky Note What's he running? ENTB is a SKIPPERANDGILLIGAN 05/20/14 11:03:15 AM
#36167   10q had a lot of decent information out. firehousestocks 11/26/14 04:56:48 PM
#36166   I see this exploding on news. Christine Ichim sizzleweed 11/26/14 01:50:37 PM
#36165   Load up! This will retrace over a penny sizzleweed 11/26/14 01:47:54 PM
#36164   Well that was depressing. chonrm 11/26/14 11:59:54 AM
#36163   Patently....Sweet.. JokersWild12 11/25/14 05:04:19 PM
#36162   Up 150% eeeeek SKIPPERANDGILLIGAN 11/25/14 02:24:03 PM
#36161   ~ ENTB = .0002+.0001 (+100.00%)! ;-) 1-eye-jack 11/25/14 01:25:27 PM
#36160   Here is a novel idea. How about move sizzleweed 11/25/14 10:45:12 AM
#36159   Awesome news GM. Christine Ichim is renowned for sizzleweed 11/25/14 10:33:12 AM
#36158   BIDS ARE BUILDING!!!!!!!!!!!! SKIPPERANDGILLIGAN 11/25/14 09:59:32 AM
#36157   SAN DIEGO, CA -- (Marketwired) -- 11/25/14 -- GM_FSJ 11/25/14 08:50:25 AM
#36156   Sizzle you are correct imho...matter of time now JokersWild12 11/24/14 10:49:47 AM
#36155   Add more cheap shares and forget about it. sizzleweed 11/24/14 01:21:16 AM
#36154   Christine Ichim will hit a home run here. sizzleweed 11/24/14 01:16:43 AM
#36153   Humdrum. ENTB is a bad winter's cold. bucks2pennies 11/23/14 08:06:28 PM
#36152   If it werent for the recruitment of the JokersWild12 11/21/14 12:37:23 PM
#36151   Cheeeeeese! I am sitting on many as well...but bucks2pennies 11/21/14 12:04:29 PM
#36150   Maybe not? Brakeman 11/21/14 10:23:39 AM
#36149   Stated so many times now...doesn't make it so. bucks2pennies 11/21/14 09:14:40 AM
#36148   Hahahahaha ! I'll sit here with my 10 Optimystic 11/20/14 09:57:47 PM
#36147   Just a WELFARE ATM for its SHYSTER CEO!! This angelicsatan666 11/20/14 07:53:02 PM
#36146   Is there a heart beat? ENTB progress bucks2pennies 11/20/14 02:29:18 PM
#36145   Patience while the research plays out...CI has only JokersWild12 11/17/14 11:02:39 AM
#36144   Dead stock walking? SKIPPERANDGILLIGAN 11/17/14 10:45:50 AM
#36143   I am loaded to the hilt on this sizzleweed 11/15/14 02:22:34 AM
#36142   Been here for almost 3 years now and firehousestocks 11/14/14 04:02:08 PM
#36141   Well for those who haven't been loading up firehousestocks 11/14/14 03:49:37 PM
#36140   One thing is for sure there is no firehousestocks 11/14/14 03:12:24 PM
#36139   BMSN will catch us, more likely! Thrashing21 11/13/14 01:37:52 PM
#36138   Looks like we just might catch BMSN Lockman 11/13/14 12:48:46 PM
#36136   First day in entb history no volume? EEEEEEEEk SKIPPERANDGILLIGAN 11/12/14 07:46:12 PM
#36133   I am VERY VERY VERY glad that the angelicsatan666 11/12/14 07:36:40 AM
#36132   I believe the ones trying to intentionally smash Brakeman 11/11/14 07:49:48 PM
#36130   I don't see much of any accumulation at firehousestocks 11/11/14 04:18:13 PM
#36129   Link? chonrm 11/11/14 01:06:35 PM
#36128   Major news leak!!! No wonder all 3 are prof81 11/11/14 10:04:55 AM
#36127   LOL, yes you are! 50+ bagger like Mick sizzleweed 11/10/14 10:27:55 PM
#36126   This is EXACTLY like the "turkey" that was angelicsatan666 11/10/14 09:35:31 PM
#36124   Im in the money! Im in the money! Weeeeeeeeeeeeeeeeeeeeeee SKIPPERANDGILLIGAN 11/10/14 01:07:38 PM
#36123   You bought back in anticipating a reverse split? sizzleweed 11/10/14 11:45:21 AM
#36122   Back in... Ave is .0002. Weeeeeeeee LETS GO ENTB SKIPPERANDGILLIGAN 11/10/14 10:27:37 AM
#36121   Reverse split next? I truly believe so. SKIPPERANDGILLIGAN 11/10/14 09:30:55 AM
#36120   On August 11, 2014 the Company issued 12,500,000 SKIPPERANDGILLIGAN 11/10/14 09:18:17 AM
#36119   Hmmmmmmmmm--how can this be SPUN to make ENTB angelicsatan666 11/09/14 07:28:12 PM
#36118   Now we wait for an update on Dr. Kbro13 11/09/14 06:46:26 PM
#36117   Ok. Now what? Optimystic 11/09/14 06:10:45 PM
#36116   Entest 8-K out: Kbro13 11/09/14 11:29:50 AM
#36115   I had bids at 1, no joy. A sizzleweed 11/08/14 01:03:13 AM
#36114   Got fed up waiting for the 1's to sizzleweed 11/08/14 12:57:18 AM
#36113   This does look like the next report will SKIPPERANDGILLIGAN 11/07/14 03:17:59 PM